CERO vs REGN: Which Stock is Better?
Side-by-side comparison of Cero Therapeutics Holdings Inc and Regeneron Pharmaceuticals Inc in 2026
CERO
Cero Therapeutics Holdings Inc
$0.04
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | CERO | REGN | Winner |
|---|---|---|---|
| Market Cap | $0.84M | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze CERO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CERO or REGN a better investment?
Comparing CERO and REGN: Cero Therapeutics Holdings Inc has a market cap of $0.84M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CERO and REGN?
CERO (Cero Therapeutics Holdings Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CERO or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CERO or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for CERO.
Which company is more profitable: CERO or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for CERO.
Which is the larger company: CERO or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $0.84M for CERO.
Should I buy CERO or REGN in 2026?
Both CERO and REGN have investment merit. CERO trades at $0.04 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CERO and REGN stock?
Key differences: Market Cap ($0.84M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).